ES2821655T3 - Vectores de ADN no integrantes para la modificación genética de células - Google Patents
Vectores de ADN no integrantes para la modificación genética de células Download PDFInfo
- Publication number
- ES2821655T3 ES2821655T3 ES17191829T ES17191829T ES2821655T3 ES 2821655 T3 ES2821655 T3 ES 2821655T3 ES 17191829 T ES17191829 T ES 17191829T ES 17191829 T ES17191829 T ES 17191829T ES 2821655 T3 ES2821655 T3 ES 2821655T3
- Authority
- ES
- Spain
- Prior art keywords
- sequence
- polynucleotide
- host cell
- selectable marker
- mar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2820/00—Vectors comprising a special origin of replication system
- C12N2820/55—Vectors comprising a special origin of replication system from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17191829.5A EP3456821B2 (fr) | 2017-09-19 | 2017-09-19 | Vecteurs d'adn non intégrants destinés à la modification génétique de cellules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2821655T3 true ES2821655T3 (es) | 2021-04-27 |
Family
ID=60037350
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17191829T Active ES2821655T3 (es) | 2017-09-19 | 2017-09-19 | Vectores de ADN no integrantes para la modificación genética de células |
| ES18769377T Active ES2942210T3 (es) | 2017-09-19 | 2018-09-19 | Vectores de ADN no integradores para modificación genética de células |
| ES18769378T Active ES2887776T3 (es) | 2017-09-19 | 2018-09-19 | Vectores de ADN no integradores para la modificación genética de células |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18769377T Active ES2942210T3 (es) | 2017-09-19 | 2018-09-19 | Vectores de ADN no integradores para modificación genética de células |
| ES18769378T Active ES2887776T3 (es) | 2017-09-19 | 2018-09-19 | Vectores de ADN no integradores para la modificación genética de células |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20200277624A1 (fr) |
| EP (4) | EP3456821B2 (fr) |
| JP (3) | JP7263327B2 (fr) |
| KR (2) | KR20200079244A (fr) |
| CN (1) | CN111278972B (fr) |
| AU (2) | AU2018337672A1 (fr) |
| CA (2) | CA3017658A1 (fr) |
| DK (3) | DK3456821T4 (fr) |
| ES (3) | ES2821655T3 (fr) |
| FI (2) | FI3456821T4 (fr) |
| HU (1) | HUE060893T2 (fr) |
| IL (2) | IL273267A (fr) |
| LT (1) | LT3684924T (fr) |
| MX (1) | MX2020003092A (fr) |
| PL (1) | PL3684924T3 (fr) |
| PT (1) | PT3684924T (fr) |
| SG (2) | SG11202001941SA (fr) |
| WO (2) | WO2019060253A1 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| EP3092049A1 (fr) | 2014-01-08 | 2016-11-16 | Flodesign Sonics Inc. | Dispositif d'acoustophorèse avec double chambre acoustophorétique |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| KR20220066413A (ko) | 2017-12-14 | 2022-05-24 | 프로디자인 소닉스, 인크. | 음향 트랜스듀서 구동기 및 제어기 |
| WO2020187889A1 (fr) * | 2019-03-18 | 2020-09-24 | Deutsches Krebsforschungszentrum | Constructions d'expression pour la modification génétique de cellules |
| CA3151464A1 (fr) | 2019-09-18 | 2021-03-25 | Bruce C. SCHNEPP | Vecteurs d'adn synthetiques et procedes d'utilisation |
| JP2023537858A (ja) | 2020-07-22 | 2023-09-06 | ドイチェス クレブスフォルシュンクスツェントルム | ５’ｓ／ｍａｒの適用 |
| CN113025651B (zh) * | 2021-03-31 | 2023-03-24 | 重庆医科大学 | 靶向HBV核心启动子的药物筛选细胞模型、Triciribine及结构类似物新应用 |
| WO2022272297A1 (fr) | 2021-06-25 | 2022-12-29 | Oxford Biomedica Solutions Llc | Systèmes de conditionnement de virus adéno-associés |
| CN118055951A (zh) | 2021-11-11 | 2024-05-17 | 海德堡大学 | 免疫反应性分子及其用途 |
| WO2023083985A1 (fr) | 2021-11-11 | 2023-05-19 | Patrick Schmidt | Molécules immunoréactives et leurs utilisations |
| US20230323395A1 (en) | 2021-12-15 | 2023-10-12 | Homology Medicines, Inc. | Methods and compositions for the production of adeno-associated virus |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5888774A (en) | 1994-12-19 | 1999-03-30 | Cangene Corporation | Recombinant DNA molecules and expression vectors for erythropoietin |
| FR2738842B1 (fr) | 1995-09-15 | 1997-10-31 | Rhone Poulenc Rorer Sa | Molecule d'adn circulaire a origine de replication conditionnelle, leur procede de preparation et leur utilisation en therapie genique |
| US5922583A (en) | 1995-10-17 | 1999-07-13 | Biostar Inc. | Methods for production of recombinant plasmids |
| DE19848017A1 (de) | 1998-10-17 | 2000-04-20 | Multigene Biotech Gmbh | Episomal replizierender Vektor zur Expression eines Transgens in Säugerzellen |
| FR2821855B1 (fr) | 2001-03-09 | 2004-04-02 | Cayla | Genes synthetiques et plasmides bacteriens depourvus de cpg |
| GB0327056D0 (en) | 2003-11-20 | 2003-12-24 | Cobra Biolog Ltd | Plasmid maintenance |
| TWI311152B (en) | 2004-09-17 | 2009-06-21 | Boehringer Ingelheim Rcv Gmbh & Co K | Host-vector system for antibiotic-free cole1 plasmid propagation |
| NZ554895A (en) * | 2004-11-03 | 2009-06-26 | Almac Diagnostics Ltd | Transcriptome microarray technology and methods of using the same |
| US9068200B2 (en) * | 2005-10-05 | 2015-06-30 | Universita' Degli Studi Milano-Bicocca | Method for the transfer of episomal vectors into animal cells |
| WO2008153733A2 (fr) | 2007-05-29 | 2008-12-18 | Nature Technology Corporation | Vecteurs et méthodes pour immunisation génétique |
| CA2726862A1 (fr) | 2008-06-30 | 2010-01-21 | Atgcell Inc. | Vecteurs d'expression dans des cellules de mammifere et leur utilisation |
| EP3093351B1 (fr) * | 2008-07-09 | 2018-04-18 | Celera Corporation | Polymorphismes génétiques associés à des maladies cardiovasculaires, procédés de détection et utilisations associées |
| AU2009280913A1 (en) * | 2008-08-12 | 2010-02-18 | Avesthagen Limited | An expression vector and a method thereof |
| US9045759B2 (en) | 2009-01-21 | 2015-06-02 | James Arthur Williams | DNA plasmids with improved copy number |
| EP2476755A1 (fr) | 2011-01-17 | 2012-07-18 | Helmholtz-Zentrum für Infektionsforschung GmbH | Vecteurs d'expression, cellules et lignées cellulaires contenant S/MAR, ainsi que leurs procédés d'utilisation |
| GB201213117D0 (en) | 2012-07-24 | 2012-09-05 | Ucl Business Plc | Transgene expression |
| US9550998B2 (en) * | 2012-08-29 | 2017-01-24 | Nature Technology Corporation | DNA plasmids with improved expression |
| US20150322439A1 (en) * | 2012-11-19 | 2015-11-12 | Nature Technology Corporation | Replicative minicircle vectors with improved expression |
| EP2878674A1 (fr) | 2013-11-28 | 2015-06-03 | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) | Épisomes stables sur la base des vecteurs lentiviraux non intégratifs |
| JP6544565B2 (ja) | 2015-04-28 | 2019-07-17 | 国立大学法人広島大学 | 哺乳動物細胞内で目的遺伝子の発現を高める方法およびキット、並びに、その利用 |
| WO2020187889A1 (fr) * | 2019-03-18 | 2020-09-24 | Deutsches Krebsforschungszentrum | Constructions d'expression pour la modification génétique de cellules |
-
2017
- 2017-09-19 EP EP17191829.5A patent/EP3456821B2/fr active Active
- 2017-09-19 FI FIEP17191829.5T patent/FI3456821T4/fi active
- 2017-09-19 DK DK17191829.5T patent/DK3456821T4/da active
- 2017-09-19 ES ES17191829T patent/ES2821655T3/es active Active
-
2018
- 2018-09-17 WO PCT/US2018/051381 patent/WO2019060253A1/fr active Application Filing
- 2018-09-17 US US16/648,885 patent/US20200277624A1/en active Pending
- 2018-09-18 CA CA3017658A patent/CA3017658A1/fr active Pending
- 2018-09-19 AU AU2018337672A patent/AU2018337672A1/en active Pending
- 2018-09-19 WO PCT/EP2018/075353 patent/WO2019057773A1/fr unknown
- 2018-09-19 ES ES18769377T patent/ES2942210T3/es active Active
- 2018-09-19 JP JP2020516608A patent/JP7263327B2/ja active Active
- 2018-09-19 KR KR1020207010722A patent/KR20200079244A/ko not_active Application Discontinuation
- 2018-09-19 PL PL18769377.5T patent/PL3684924T3/pl unknown
- 2018-09-19 ES ES18769378T patent/ES2887776T3/es active Active
- 2018-09-19 LT LTEPPCT/EP2018/075353T patent/LT3684924T/lt unknown
- 2018-09-19 HU HUE18769377A patent/HUE060893T2/hu unknown
- 2018-09-19 SG SG11202001941SA patent/SG11202001941SA/en unknown
- 2018-09-19 US US16/649,064 patent/US20200263195A1/en not_active Abandoned
- 2018-09-19 EP EP18769378.3A patent/EP3684925B1/fr active Active
- 2018-09-19 US US16/648,768 patent/US20210403941A1/en active Pending
- 2018-09-19 EP EP22201555.4A patent/EP4186975A1/fr active Pending
- 2018-09-19 CA CA3076285A patent/CA3076285A1/fr active Pending
- 2018-09-19 FI FIEP18769377.5T patent/FI3684924T3/fi active
- 2018-09-19 DK DK18769377.5T patent/DK3684924T3/da active
- 2018-09-19 EP EP18769377.5A patent/EP3684924B1/fr active Active
- 2018-09-19 JP JP2020516915A patent/JP7189943B2/ja active Active
- 2018-09-19 MX MX2020003092A patent/MX2020003092A/es unknown
- 2018-09-19 PT PT187693775T patent/PT3684924T/pt unknown
- 2018-09-19 DK DK18769378.3T patent/DK3684925T3/da active
- 2018-09-19 SG SG11202002367WA patent/SG11202002367WA/en unknown
- 2018-09-19 CN CN201880061036.7A patent/CN111278972B/zh active Active
- 2018-09-19 AU AU2018337673A patent/AU2018337673A1/en active Pending
- 2018-09-19 KR KR1020207010863A patent/KR20200054278A/ko not_active Application Discontinuation
-
2020
- 2020-03-12 IL IL273267A patent/IL273267A/en unknown
- 2020-03-17 IL IL273362A patent/IL273362A/en unknown
-
2023
- 2023-04-12 JP JP2023064820A patent/JP2023089132A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2821655T3 (es) | Vectores de ADN no integrantes para la modificación genética de células | |
| US20180265890A1 (en) | Efficient and safe transposon integration system and use thereof | |
| ES2378333T3 (es) | Métodos y composiciones para la inactivación de genes | |
| RU2361611C2 (ru) | Конструирование рекомбинанта онколитического аденовируса, специфически экспрессирующего иммуномодуляторный фактор gm-csf в опухолевых клетках, и его применение | |
| JP2004222733A (ja) | テトラサイクリンリプレッサーによる哺乳動物細胞における転写およびウイルス複製の調節 | |
| JP2020500541A (ja) | ヒト化デュシェンヌ型筋ジストロフィー変異を有するｄｍｄレポーターモデル | |
| KR101478869B1 (ko) | 마이크로ｒｎａ를 이용한 조절을 통한 암 특이적 유전자 치료제 | |
| Lee et al. | Prevention of autoimmune insulitis by delivery of a chimeric plasmid encoding interleukin-4 and interleukin-10 | |
| Vilaboa et al. | Gene switches for deliberate regulation of transgene expression: recent advances in system development and uses | |
| US20220226506A1 (en) | Expression constructs for the genetic modification of cells | |
| JP2023552535A (ja) | 異種導入遺伝子の発現を制御するためのオーファンモチーフ（ｏｒｐｈａｎ ｍｏｔｉｆ）とＣｐＧ密度との組み合わせの使用 | |
| ES2339113T3 (es) | Plasmido vegf inducible por la hipoxia para una enfermedad isquemica. | |
| JP2013034401A (ja) | アストロサイトで遺伝子を発現させるためのベクター | |
| Kang et al. | The piggyBac transposon is an integrating non-viral gene transfer vector that enhances the efficiency of GDEPT | |
| JP6153205B2 (ja) | Ｖａ遺伝子破壊アデノウイルスベクターおよびそれを調製するための前駆体ベクター | |
| Matsuyama et al. | Novel and Efficient Plasmid Transfection Protocols for Functional Analysis of Genetic Elements in Human Cardiac Fibroblasts | |
| WO2021168266A1 (fr) | Éradication de polyomavirus de cellules de merkel | |
| KR20210139306A (ko) | 강력한 암 치료제로서의 융합체 종양용해성 단순 헤르페스 돌연변이체 | |
| EP4221740A1 (fr) | Éradication de l'herpès simplex de type i et d'autres virus de l'herpès associés guidée par arn | |
| RU2551784C1 (ru) | Универсальный промотор для экспрессии терапевтических генов в клетках млекопитающих | |
| ES2954867A1 (es) | Acido nucleico y su uso en el tratamiento del sarcoma de ewing | |
| Csonka | Generation of prototype human satellite DNA-based artificial chromosomes |